SALA, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 5.635
AS - Asia 3.624
EU - Europa 2.679
SA - Sud America 496
Continente sconosciuto - Info sul continente non disponibili 384
AF - Africa 94
OC - Oceania 3
Totale 12.915
Nazione #
US - Stati Uniti d'America 5.410
SG - Singapore 1.216
IT - Italia 832
VN - Vietnam 740
CN - Cina 723
RU - Federazione Russa 414
BR - Brasile 371
HK - Hong Kong 352
DE - Germania 349
IE - Irlanda 169
SE - Svezia 161
CA - Canada 152
GB - Regno Unito 144
PL - Polonia 117
FR - Francia 115
IN - India 115
BD - Bangladesh 108
UA - Ucraina 82
KR - Corea 77
ID - Indonesia 68
FI - Finlandia 63
NL - Olanda 54
AR - Argentina 46
AT - Austria 44
DK - Danimarca 38
ZA - Sudafrica 36
TR - Turchia 33
JP - Giappone 31
IQ - Iraq 28
MX - Messico 28
EC - Ecuador 26
ES - Italia 26
PK - Pakistan 20
SA - Arabia Saudita 20
CO - Colombia 18
PH - Filippine 17
UZ - Uzbekistan 16
CH - Svizzera 14
VE - Venezuela 14
MY - Malesia 12
BE - Belgio 11
LT - Lituania 11
MA - Marocco 11
CL - Cile 8
CR - Costa Rica 8
DO - Repubblica Dominicana 6
JO - Giordania 6
SN - Senegal 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
EG - Egitto 5
KE - Kenya 5
PE - Perù 5
DZ - Algeria 4
EE - Estonia 4
ET - Etiopia 4
EU - Europa 4
GT - Guatemala 4
IR - Iran 4
JM - Giamaica 4
NP - Nepal 4
OM - Oman 4
PT - Portogallo 4
RO - Romania 4
SC - Seychelles 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AL - Albania 3
AO - Angola 3
AZ - Azerbaigian 3
NG - Nigeria 3
NI - Nicaragua 3
NO - Norvegia 3
PA - Panama 3
PR - Porto Rico 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CU - Cuba 2
CY - Cipro 2
CZ - Repubblica Ceca 2
GD - Grenada 2
GY - Guiana 2
HN - Honduras 2
IL - Israele 2
KW - Kuwait 2
LB - Libano 2
MN - Mongolia 2
MT - Malta 2
NA - Namibia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SV - El Salvador 2
AG - Antigua e Barbuda 1
AU - Australia 1
BF - Burkina Faso 1
Totale 12.521
Città #
Singapore 747
San Jose 652
Ashburn 647
Ann Arbor 492
Hong Kong 342
Milan 260
Ho Chi Minh City 224
Woodbridge 203
Wilmington 192
Hanoi 177
Fairfield 176
Dublin 161
New York 151
Houston 149
Hefei 148
Frankfurt am Main 143
Council Bluffs 131
Santa Clara 130
Chandler 115
Beijing 100
Dallas 100
Kraków 94
Los Angeles 92
Chicago 88
Seattle 86
Dearborn 83
Seoul 73
Cambridge 65
Jacksonville 65
Boardman 60
Toronto 56
Rome 54
The Dalles 52
Jakarta 51
São Paulo 50
Moscow 47
Buffalo 41
Lauterbourg 38
Da Nang 35
Vienna 35
Princeton 34
Columbus 33
Shanghai 33
Helsinki 30
Nanjing 29
Phoenix 29
Chennai 27
Dong Ket 26
Orem 25
Tokyo 25
Haiphong 24
Atlanta 23
Denver 23
Warsaw 23
Brooklyn 20
Johannesburg 19
Montreal 19
Figino 18
Munich 18
Stockholm 17
Padova 15
Turin 15
Altamura 14
Hyderabad 14
Lawrence 14
London 14
Ottawa 14
Salt Lake City 14
Tashkent 14
Amsterdam 13
Florence 13
Hải Dương 13
Nanchang 13
Tianjin 13
Vũng Tàu 13
Biloxi 12
Manchester 12
Nuremberg 12
Quận Bình Thạnh 12
Washington 12
Biên Hòa 11
Can Tho 11
Hebei 11
Lappeenranta 11
Turku 11
Brussels 10
Guayaquil 10
Mumbai 10
Poplar 10
Rio de Janeiro 10
Torino 10
Baghdad 9
Boston 9
Bắc Ninh 9
Campinas 9
Fremont 9
Guangzhou 9
Jinan 9
Lachine 9
Mexico City 9
Totale 7.562
Nome #
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 518
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 504
Action potential contour contributes to species differences in repolarization response to b-adrenergic stimulation 487
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young 473
Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients 468
Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension 428
Prevention of myocardial remodeling by chronic INaL blockade in pulmonary hypertension 426
Late sodium current (INaL) in pancreatic β-cells 408
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 404
Altered functional differentiation of mesoangioblasts in a genetic myopathy 402
Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes 368
IKr Impact on Repolarization and Its Variability Assessed by Dynamic Clamp 366
Aberrant Functional Differentiation of Cardiac Precursors from a Dystrophic Mouse 360
The Dynamic Clamp Technique: A Robust Toolkit for Investigating Potassium Channel Function 353
Post-natal cardiomyocytes can generate iPS cells with an enhanced capacity toward cardiomyogenic re-differentation 335
Membrane-targeted push-pull azobenzenes for the optical modulation of membrane potential 326
Musclemotion: A versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo 304
Long QT Syndrome modelled with human induced pluripotent stem cells (hiPSc) 289
Identification and functional characterisation of a new KCNJ2 mutation 274
A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytes 270
Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation 250
Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry 241
Multiplexed Assays of Variant Effect and Automated Patch Clamping Improve KCNH2-LQTS Variant Classification and Cardiac Event Risk Stratification 213
Geneless optomodulation of cardiomyocytes membrane potential by sarcolemma-targeted azobenzene photoswitches 211
The impact of genetics on the long QT syndrome: myth or reality? 200
Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19 194
Cardiomyocyte and stromal cell cross-talk influences the pathogenesis of arrhythmogenic cardiomyopathy: a multi-level analysis uncovers DLK1-NOTCH pathway role in fibro-adipose remodelling 189
Cardiac microtissues from human pluripotent stem cells recapitulate the phenotype of long-QT syndrome 187
Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2 187
Use of hiPSC-derived cardiomyocytes to study LQTS-variant specific proarrhythmic effects of drugs 185
Estimating the Posttest Probability of Long QT Syndrome Diagnosis for Rare KCNH2 Variants 184
Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes Carrying CALM1-F142l Mutation Recapitulate LQTS Phenotype in Vitro 183
Geneless optomodulation of cardiomyocytes membrane potential by membrane-targeted azobenzene photoswitches 173
Continuous Bayesian Variant Interpretation Accounts for Incomplete Penetrance among Mendelian Cardiac Channelopathies 173
Rescue of loss-of-function long QT syndrome-associated mutations in KV7.1/KCNE1 by the endocannabinoid N-arachidonoyl-L-serine (ARA-S) 167
Precision Medicine and cardiac channelopathies: When dreams meet reality 151
Advances in pluripotent stem cell-based in vitro models of the human heart for cardiac physiology, disease modeling and clinical applications 148
Electrophysiological analysis of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) using multi-electrode arrays (MEAs) 146
Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease 141
Cardiac Repolarization and Stem Cells: An Emerging Path Toward Precision Medicine 136
Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells 136
Long QT Syndrome modelling with cardiomyocytes derived from human-induced pluripotent stem cells 133
A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells 132
Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come? 131
Quantification of Muscle Contraction In Vitro and In Vivo Using MUSCLEMOTION Software: From Stem Cell-Derived Cardiomyocytes to Zebrafish and Human Hearts 127
Isogenic Sets of hiPSC-CMs Harboring Distinct KCNH2 Mutations Differ Functionally and in Susceptibility to Drug-Induced Arrhythmias 123
Simultaneous measurement of excitation-contraction coupling parameters identifies mechanisms underlying contractile responses of hiPSC-derived cardiomyocytes 122
Precision versus traditional medicine - Clinical questions trigger progress in basic science: A favor not always returned 99
A platform for assessing pro- and anti-arrhythmic effects of drugs based on isogenic human iPSC-derived cardiomyocytes 81
A novel optoelectronic platform combining LED-driven pacing and laser optoporation for high-throughput cardiac electrophysiology 50
High-throughput contractility analysis platform for drug-response evaluation of hiPSC-derived cardiac models based on dynamic frequency conditioning 49
Non-invasive action potential recordings using printed electrolyte-gated polymer field-effect transistors 46
Cardiomyocyte-stromal cell interplay modulates the pathogenesis of arrhythmogenic cardiomyopathy 46
Beyond Transconductance: Cell-Polymer Coupling Determines Fidelity in Action Potential Recording via Electrolyte-Gated Polymer Transistors 44
SGK1-inhibition restores cardiac repolarization in LQT2 rabbits and LQT3 mice by reducing late sodium current 33
Cardiomyocyte - stromal cells interplay as a novel platform for mechanistic insights in arrhythmogenic cardiomyopathy 32
null 29
VAE-MOTION: A deep generative model for cardiomyocyte contractility analysis for improving drug efficacy evaluation 29
Machine learning-guided risk stratification for long QT syndrome genetic variants with hiPSC-derived cardiomyocytes 28
An organic artificial cardiomyocyte 23
Totale 12.915
Categoria #
all - tutte 40.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.306


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022231 0 0 0 24 10 32 15 17 19 36 28 50
2022/2023632 63 162 52 54 24 70 15 88 60 13 21 10
2023/2024694 13 18 34 41 80 167 127 45 70 22 13 64
2024/20252.213 74 215 218 71 139 85 124 89 167 351 174 506
2025/20265.308 673 434 341 596 576 239 894 213 380 413 250 299
2026/20271.280 127 374 550 229 0 0 0 0 0 0 0 0
Totale 12.915